Chitosan/pshRNA plasmid nanoparticles targeting MDR1 gene reverse paclitaxel resistance in ovarian cancer cells

Y Yang, Z Wang, M Li, S Lu - Journal of Huazhong University of Science …, 2009 - Springer
In order to investigate the effect of chitosan/pshRNA plasmid nanoparticles targeting MDR1
genes on the resistance of A2780/TS cells to paclitaxel, chitosan/pshRNA plasmid …

[HTML][HTML] Biocompatible AIEgen/p-glycoprotein siRNA@ reduction-sensitive paclitaxel polymeric prodrug nanoparticles for overcoming chemotherapy resistance in …

J Wu, Q Wang, X Dong, M Xu, J Yang, X Yi, B Chen… - Theranostics, 2021 - ncbi.nlm.nih.gov
Nanoparticle drug delivery system (NDDS) is quite different from the widely studied
traditional chemotherapy which suffers from drug resistance and side effect. NDDS offers the …

A nano-targeted co-delivery system based on gene regulation and molecular blocking strategy for synergistic enhancement of platinum chemotherapy sensitivity in …

M Song, Z Fang, J Wang, K Liu - International Journal of Pharmaceutics, 2023 - Elsevier
Ovarian cancer (OC) has a low five-year survival rate, mainly because of its drug resistance
to chemotherapy. It is the key to reverse drug resistance to combine multiple sensitization …

Cisplatin and paclitaxel co-delivery nanosystem for ovarian cancer chemotherapy

Q Wang, C Wu, X Li, D Yang, L Shi - Regenerative Biomaterials, 2021 - academic.oup.com
We have designed and developed an effective drug delivery system using biocompatible
polymer of poly (ethylene glycol)-polyaspartic acid (mPEG-PAsp) for co-loading the …

Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP

X Dong, CA Mattingly, MT Tseng, MJ Cho, Y Liu… - Cancer research, 2009 - AACR
To test the ability of nanoparticle formulations to overcome P-glycoprotein (P-gp)–mediated
multidrug resistance, several different doxorubicin and paclitaxel-loaded lipid nanoparticles …

Paclitaxel nanoparticle inhibits growth of ovarian cancer xenografts and enhances lymphatic targeting

H Lu, B Li, Y Kang, W Jiang, Q Huang, Q Chen… - Cancer chemotherapy …, 2007 - Springer
Objectives: Ovarian cancer has the highest mortality of all the gynecologic cancers. The
antitumor agent paclitaxel has been proved to be efficient in the treatment of ovarian cancer …

Nano-based drug delivery and targeting to overcome drug resistance of ovarian cancers

M McFadden, SK Singh, G Oprea-Ilies, R Singh - Cancers, 2021 - mdpi.com
Simple Summary Ovarian cancer (OvCa) is a prominent cause of cancer death in women
due to missed early signs and late diagnoses. Once a woman is diagnosed with OvCa, the …

Chitosan coated polylactic acid nanoparticle-mediated combinatorial delivery of cisplatin and siRNA/Plasmid DNA chemosensitizes cisplatin-resistant human ovarian …

A Babu, Q Wang, R Muralidharan… - Molecular …, 2014 - ACS Publications
Development of resistance toward anticancer drugs results in ineffective therapy leading to
increased mortality. Therefore, overriding resistance and restoring sensitivity to anticancer …

The combined use of paclitaxel-loaded nanoparticles with a low-molecular-weight copolymer inhibitor of P-glycoprotein to overcome drug resistance

CPL Wan, K Letchford, JK Jackson… - International journal of …, 2013 - Taylor & Francis
Two types of nanoparticles were prepared using the diblock copolymer methoxy poly
(ethylene glycol)-block-poly (caprolactone)(MePEG-b-PCL), with either a short PCL block …

In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy

MT Luiz, JP Abriata, GL Raspantini, LB Tofani… - Materials Science and …, 2019 - Elsevier
Ovarian cancer is the most lethal gynecological cancer of female reproductive system. In
order to improve the survival rate, some modifications on nanoparticles surfaces have been …